Role of Lipocalin 24p3 in Apoptosis and Leukemia
Role of Lipocalin 24p3 in Apoptosis and Leukemia
批准号:
7355590
负责人:
MICHAEL R GREEN
金额:
$25.21万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-12 至 2011-02-28
关键词:
Animal ModelApoptosisApoptoticCell DeathCell LineCell Surface ReceptorsCell SurvivalCellsChelating AgentsChronic Myeloid LeukemiaDiseaseGene ActivationGenesGenetic TranscriptionGlucocorticoidsGoalsGrowth FactorHelper-Inducer T-LymphocyteImatinibInduction of ApoptosisInterleukin-3IronKnockout MiceLaboratoriesLeucine ZippersLymphoid CellMalignant lymphoid neoplasmMediatingModelingMolecularMolecular ProfilingMusMyeloproliferative diseasePathway interactionsPatientsPhysiologicalPhysiologyPlayProteinsRNA InterferenceResistanceRoleSamplingTranscriptional Activationautocrinebasebcr-abl Fusion Proteinscancer cellcancer therapycell transformationchemotherapeutic agentcytokinedeprivationkillingsleukemianovelparacrineprogramsresearch studytranscription factor
中文摘要
细胞程序性死亡,即细胞凋亡,是正常生理的一个重要方面,也是细胞的发生和发展的一个重要方面。
癌症的治疗。某些凋亡途径是转录调控的;在这些情况下,细胞凋亡是
由编码促凋亡蛋白的基因转录激活而诱导的。此应用程序侧重于
关于我们实验室发现的24p3/24p3R转录调控的促凋亡途径
在过去的几年里我一直在学习。我们最初确定24p3是经历最大
去细胞因子白介素3诱导细胞凋亡后的转录刺激
从属细胞。24p3是一种分泌型的Lipocalin,我们发现当它与
各种淋巴样细胞。这些和其他结果揭示了一种模型,在该模型中,剥夺IL-3激活24p3
转录,导致24p3的合成和分泌,从而通过
自分泌/旁分泌途径。我们分离了24p3细胞表面受体(24p3R),发现24p3
通过一种新的途径诱导细胞凋亡,最终导致细胞内铁水平下降。这个
细胞内铁的减少会诱导促凋亡蛋白Bim的表达,从而导致细胞凋亡。
细胞内铁传递阻断BIM的诱导并抑制24p3添加或IL-3引起的细胞凋亡
剥夺。在这一应用中,我们提出了实验来研究24p3/24p3R促凋亡的作用
利用细胞系、患者样本和动物研究正常生理和骨髓增殖性疾病的途径
模特们。细胞内铁减少诱导细胞凋亡的基础尚不清楚。我们会
继续研究24p3和铁络合剂诱导的细胞凋亡途径。表达特征分析
RNA干扰将被用来识别24p3-和铁相关的转录激活基因
螯合剂介导的细胞凋亡。我们的初步结果提示24p3/24p3R通路可能在
糖皮质激素介导的细胞凋亡和糖皮质激素耐药,我们将继续研究。我们
已经发现BCR-ABL癌蛋白通过以下方式中和24p3/24p3R促凋亡途径
24p3和24p3R表达失调。这些结果揭示了一个新的和意想不到的方面
Bcr-abl促进细胞存活的机制。我们将继续分析这方面的一般性
结果研究了24p3和24p3R转录失控的基础。我们已经推导出24p3
纯合子基因敲除小鼠,将用于研究24p3/24p3R促凋亡的作用
Bcr/abl诱导的骨髓增殖性疾病的途径。
英文摘要
Programmed cell death, apoptosis, is a critical aspect of normal physiology as well as the genesis and
treatment of cancer. Certain apoptotic pathways are transcriptionally regulated; in these cases, apoptosis is
induced by the transcriptional activation of genes encoding proapoptotic proteins. This application focuses
on the 24p3/24p3R transcriptionally-regulated proapoptotic pathway that our laboratory discovered and has
been studying for the past several years. We originally identified 24p3 as the gene undergoing maximum
transcriptional stimulation following induction of apoptosis by cytokine-deprivation of interleukin 3 (IL-3)
dependent cells. 24p3 is a secreted lipocalin, which we have found induces apoptosis when added to a
variety of lymphoid cells. These and other results revealed a model in which IL-3deprivation activates 24p3
transcription, leading to synthesis and secretion of 24p3, which induces apoptosis through an
autocrine/paracrine pathway. We have isolated the 24p3 cell surface receptor (24p3R) and found that 24p3
induces apoptosis through a novel pathway culminating in a decrease in intracellular iron levels. The
decrease in intracellular iron induces expression of the proapoptotic protein Bim, resulting in apoptosis.
Intracellular iron delivery blocks induction of Bim and suppresses apoptosis due to 24p3 addition or IL-3
deprivation. In this application we propose experiments to study the role of the 24p3/24p3R proapoptotic
pathway in normal physiology and myeloproliferative disease using cell lines, patient samples and animal
models. The basis by which decreased intracellular iron induces apoptosis is not well understood. We will
continue to characterize the apoptotic pathway induced by 24p3 and by iron chelators. Expression profiling
and RNA interference will be used to identify transcriptionally activated genes involved in 24p3- and iron
chelator-mediated apoptosis. Our preliminary results suggest a possible role for the 24p3/24p3R pathway in
glucocorticoid-mediated apoptosis and glucocorticoid-resistance, which we will continue to investigate. We
have found that the BCR-ABL oncoprotein counteracts the 24p3/24p3R proapoptotic pathway by
misregulating expression of 24p3 and 24p3R. These results reveal a new and unanticipated aspect of the
mechanism by which BCR-ABL promotes cell survival. We will continue to analyze the generality of this
result and study the basis by which 24p3 and 24p3R transcription is misregulated. We have derived 24p3
homozygous knockout mice, which will be used to study the contribution of the 24p3/24p3R proapoptotic
pathway to BCR/ABL-induced myeloproliferative disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transcriptional Upregulation of the Epigenetically Repressed FXN Gene as a Therapeutic Approach for Friedreich Ataxia
-
批准号:10020200
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2019
-
负责人:MICHAEL R GREEN
-
依托单位:
Transcriptional Upregulation of the Epigenetically Repressed FXN Gene as a Therapeutic Approach for Friedreich Ataxia
-
批准号:10171630
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2019
-
负责人:MICHAEL R GREEN
-
依托单位:
A Novel Druggable Epigenetic Vulnerability Pathway in HCC
-
批准号:9901470
-
项目类别:
-
资助金额:$59.05万
-
财政年份:2018
-
负责人:MICHAEL R GREEN
-
依托单位:
A Novel Druggable Epigenetic Vulnerability Pathway in HCC
-
批准号:10133462
-
项目类别:
-
资助金额:$58.51万
-
财政年份:2018
-
负责人:MICHAEL R GREEN
-
依托单位:
Reactivation of Epigenetically Silenced FMR1 as a Therapeutic Approach for Fragile X Syndrome
-
批准号:10217959
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2017
-
负责人:MICHAEL R GREEN
-
依托单位:
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
-
批准号:8733134
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2013
-
负责人:MICHAEL R GREEN
-
依托单位:
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
-
批准号:8578767
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2013
-
负责人:MICHAEL R GREEN
-
依托单位:
Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia
-
批准号:9293268
-
项目类别:
-
资助金额:$34.76万
-
财政年份:2013
-
负责人:MICHAEL R GREEN
-
依托单位:
Role of Lipocalin 24p3 in Apoptosis and Leukemia
-
批准号:7572913
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:MICHAEL R GREEN
-
依托单位:
Role of Lipocalin 24p3 in Apoptosis and Leukemia
-
批准号:7221162
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:MICHAEL R GREEN
-
依托单位:
Role of Lipocalin 24p3 in Apoptosis and Leukemia
-
批准号:7766916
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:MICHAEL R GREEN
-
依托单位:
Role of Lipocalin 24p3 in Apoptosis and Leukemia
-
批准号:7094964
-
项目类别:
-
资助金额:$25.94万
-
财政年份:2006
-
负责人:MICHAEL R GREEN
-
依托单位:
CONFERENCE--TRANSCRIPTION REGULATION
-
批准号:3434748
-
项目类别:
-
资助金额:$0.2万
-
财政年份:1992
-
负责人:MICHAEL R GREEN
-
依托单位:
HIV-1 REV PROTEIN--BIOCHEMICAL MECHANISMS
-
批准号:6169685
-
项目类别:
-
资助金额:$27.76万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
HIV-1 REV PROTEIN--BIOCHEMICAL MECHANISMS
-
批准号:2672095
-
项目类别:
-
资助金额:$25.7万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
Intracellular Localization of HIV-1 RNAs by Rev&Matrix
-
批准号:6631919
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
HIV-1 REV PROTEIN--BIOCHEMICAL MECHANISMS
-
批准号:2886725
-
项目类别:
-
资助金额:$26.71万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
Intracellular Localization of HIV-1 RNAs by Rev&Matrix
-
批准号:6876153
-
项目类别:
-
资助金额:$27.83万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
HIV-1 REV PROTEIN--BIOCHEMICAL MECHANISMS
-
批准号:2066863
-
项目类别:
-
资助金额:$24.03万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
Intracellular Localization of HIV-1 RNAs by Rev&Matrix
-
批准号:6409044
-
项目类别:
-
资助金额:$26.09万
-
财政年份:1991
-
负责人:MICHAEL R GREEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: